Research
Hormonal
Prebiotic supplementation (inulin, oligofructose, galactooligosaccharides) modulates gut microbiota (increasing Bifidobacterium) and improves metabolic markers in overweight or obese individuals.
Supplementing with prebiotics like inulin or oligofructose (e.g., 50/50 mix) for 16 weeks can help reduce body fat and trunk fat in overweight or obese individuals, including children, by improving gut microbiota composition.
ModerateSupportsMEDIUM confidence
16 semanas, a suplementação com prebióticos normalizou o ganho de peso, reduziu significativamente o percentual de gordura corporal e de gordura do tronco, bem como alterou significativamente a composição microbiana intestinal, incluindo aumento de Bifidobacterium spp
Why this rating
Based on RCTs cited, but effects vary by individual microbiota composition.
Source
CONSUMO DE PREBIÓTICOS, PROBIÓTICOS E TERAPIA FAMACOLÓGICA E SUA RELAÇÃO COM A MODULAÇÃO INTESTINAL NO TRATAMENTO DA OBESIDADE: UMA REVISÃO DA LITERATURA
Gabriela Cristina Uebel et al. · Revista Contemporânea · 2023
DOI 10.56083/rcv3n12-093
narrative_reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Administration of GLP-1 receptor agonists (semaglutide 2.4 mg weekly or liraglutide 3.0 mg daily) combined with lifestyle interventions significantly reduces body weight and modulates gut microbiota composition in adults with obesity.Good
- Supplementation with specific probiotics (e.g., Lactobacillus gasseri SBT2055, Lactobacillus curvatus HY7601, and Lactobacillus plantarum KY1032) reduces abdominal adiposity and body weight in overweight or obese individuals.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →